Open AccessBevacizumab is an effective treatment for symptomatic cerebral necrosis after carbon ion therapy for recurrent intracranial malignant tumours: A case report
Author(s) -
Ruifeng Liu,
Hongtao Luo,
Qiuning Zhang,
Shilong Sun,
Zhiqiang Liu,
Xiaohu Wang,
Yichao Geng,
Xueshan Zhao
Publication year - 2022
Publication title -
molecular and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2022.2547
Subject(s) - bevacizumab , medicine , magnetic resonance imaging , radiology , cancer , chemotherapy , surgery
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom